Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Struthers

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Cell Reports. Medicine|August 20, 2025
TYK2 inhibition enhances Treg differentiation and function while preventing Th1 and Th17 differentiationKaroliina Tuomela, Rosa V Garcia, Dominic A Boardman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 5, 2018
IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T CellsNatasha C Ward, Aixin Yu, Alejandro Moro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2021
Mouse IL-2/CD25 Fusion Protein Induces Regulatory T Cell Expansion and Immune Suppression in Preclinical Models of Systemic Lupus ErythematosusJenny H Xie, Yifan Zhang, Martine Loubeau, et al.
Cellular Immunology|April 13, 2010
Synthesis and immunological activities of novel agonists of toll-like receptor 9Mary Struthers, Andrew J Bett, Thomas Wisniewski, et al.
Journal of Leukocyte Biology|September 14, 2017
A novel function of CXCL10 in mediating monocyte production of proinflammatory cytokinesQihong Zhao, Taeg Kim, Jian Pang, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2015
Discovery of benzamides as potent human β3 adrenergic receptor agonistsCheng Zhu, Nam F Kar, Bing Li, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2009
Design, synthesis, and structure-activity relationship of novel CCR2 antagonistsShankaran Kothandaraman, Karla L Donnely, Gabor Butora, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2016
Imidazopyridyl compounds as aldosterone synthase inhibitorsBrent R Whitehead, Michael M-C Lo, Amjad Ali, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2010
Heterocyclic acetamide and benzamide derivatives as potent and selective beta3-adrenergic receptor agonists with improved rodent pharmacokinetic profilesStephen D Goble, Liping Wang, K Lulu Howell, et al.
Bioorganic & Medicinal Chemistry Letters|April 19, 2017
Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertensionScott B Hoyt, Jerry Taylor, Clare London, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cell Reports. Medicine|August 20, 2025
TYK2 inhibition enhances Treg differentiation and function while preventing Th1 and Th17 differentiationKaroliina Tuomela, Rosa V Garcia, Dominic A Boardman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 5, 2018
IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T CellsNatasha C Ward, Aixin Yu, Alejandro Moro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2021
Mouse IL-2/CD25 Fusion Protein Induces Regulatory T Cell Expansion and Immune Suppression in Preclinical Models of Systemic Lupus ErythematosusJenny H Xie, Yifan Zhang, Martine Loubeau, et al.
Cellular Immunology|April 13, 2010
Synthesis and immunological activities of novel agonists of toll-like receptor 9Mary Struthers, Andrew J Bett, Thomas Wisniewski, et al.
Journal of Leukocyte Biology|September 14, 2017
A novel function of CXCL10 in mediating monocyte production of proinflammatory cytokinesQihong Zhao, Taeg Kim, Jian Pang, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2015
Discovery of benzamides as potent human β3 adrenergic receptor agonistsCheng Zhu, Nam F Kar, Bing Li, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2009
Design, synthesis, and structure-activity relationship of novel CCR2 antagonistsShankaran Kothandaraman, Karla L Donnely, Gabor Butora, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2016
Imidazopyridyl compounds as aldosterone synthase inhibitorsBrent R Whitehead, Michael M-C Lo, Amjad Ali, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2010
Heterocyclic acetamide and benzamide derivatives as potent and selective beta3-adrenergic receptor agonists with improved rodent pharmacokinetic profilesStephen D Goble, Liping Wang, K Lulu Howell, et al.
Bioorganic & Medicinal Chemistry Letters|April 19, 2017
Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertensionScott B Hoyt, Jerry Taylor, Clare London, et al.
Pageof 3